Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
2.420
-0.140 (-5.47%)
At close: Apr 24, 2024, 4:00 PM
2.480
+0.060 (2.48%)
After-hours: Apr 24, 2024, 7:47 PM EDT
Standard BioTools Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Standard BioTools stock have an average target of 3.58, with a low estimate of 3.25 and a high estimate of 4.00. The average target predicts an increase of 47.93% from the current stock price of 2.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LAB stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +44.63% | Apr 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $3.25 | Strong Buy | Initiates | $3.25 | +34.30% | Apr 4, 2024 |
| Keybanc | Keybanc | Buy Initiates $4 | Buy | Initiates | $4 | +65.29% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
202.02M
from 106.34M
Increased by 89.98%
Revenue Next Year
233.30M
from 202.02M
Increased by 15.48%
EPS This Year
-0.37
from -0.94
EPS Next Year
-0.17
from -0.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 210.0M | 246.8M | 315.0M |
| Avg | 202.0M | 233.3M | 282.8M |
| Low | 196.0M | 222.4M | 254.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 97.5% | 22.1% | 35.0% |
| Avg | 90.0% | 15.5% | 21.2% |
| Low | 84.3% | 10.1% | 9.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.31 | -0.16 | 0.02 |
| Avg | -0.37 | -0.17 | 0.02 |
| Low | -0.42 | -0.18 | 0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.